The Swedish government will initiate a million investment in a center for clinical trials, based in Gothenburg.
This was announced by the Minister for Education, Jan Björklund, during his summer speech on August 3. The aim with the investment is to strengthen the co-ordination between the pharmaceutical industry, hospitals and universitites as new medicines are introduced. The hope is that the increased collaboration will fortify the pharmaceutical industry primarily, and healthcare secondly. The Swedish pharmaceutical sector will thereby become more competitive.
The new investment will be allocated SEK 40 million in 2015 and SEK 50 million annually starting from 2016. The center will belong to the Swedish Research Council but be placed in Gothenburg for several reasons, according to Björklund, one being that Gothenburg has an existing structure for the collaboration to build on.